All changes for the tissue nervous system (767)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA742
Motor function impairment evident in altered gait and balance
Physiological
nervous system
Human
—
—
DAA1943
Motor coordination decreases
Physiological
musculoskeletal system, nervous system
Mouse
—
—
DAA1983
Critical decline in fine motor hand movements
Physiological
nervous system
Human
—
—
DAA757
Parkinsonian signs
Physiological
nervous system
Human
—
—
DAA1941
Gait width increases
Physiological
nervous system
Mouse
—
—
DAA606
Cancer of meninges, brain and other parts of central nervous system
Pathological
central nervous system
Human
—
SeriesMorbidity
DAA614
Parkinson's disease
Pathological
central nervous system
Human
—
SeriesMorbidity
DAA715
Lipid biosynthesis decreases
Physiological
central nervous system
Human
—
—
DAA723
Accumulation of extracellular neuritic plaques
Physiological
brain
Human
—
—
DAA4
actin, beta
Molecular
brain
Human
ACTB
4.0% Decrease Gene Expression Level
DAA15
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
Molecular
brain
Human
ATP2A2
9.0% Decrease Gene Expression Level
DAA7
aldehyde dehydrogenase 9 family, member A1
Molecular
brain
Human
ALDH9A1
10.0% Increase Gene Expression Level
DAA5
actin-like 6A
Molecular
brain
Human
ACTL6A
21.0% Increase Gene Expression Level
DAA235
transgelin 3
Molecular
brain
Human
TAGLN3
5.0% Decrease Gene Expression Level
DAA21
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2
Molecular
brain
Human
ATP6V1G2
7.0% Decrease Gene Expression Level
DAA3
actin, alpha 1, skeletal muscle
Molecular
brain
Human
ACTA1
16.0% Decrease Gene Expression Level
DAA8
angiomotin
Molecular
brain
Human
AMOT
10.0% Increase Gene Expression Level
DAA12
adaptor-related protein complex 1, sigma 1 subunit
Molecular
brain
Human
AP1S1
12.0% Decrease Gene Expression Level
DAA1
abhydrolase domain containing 14A
Molecular
brain
Human
ABHD14A
3.0% Decrease Gene Expression Level
DAA9
ankyrin 2, neuronal
Molecular
brain
Human
ANK2
20.0% Decrease Gene Expression Level
DAA11
annexin A4
Molecular
brain
Human
ANXA4
11.0% Increase Gene Expression Level
DAA22
antizyme inhibitor 1
Molecular
brain
Human
AZIN1
11.0% Decrease Gene Expression Level
DAA6
AHNAK nucleoprotein
Molecular
brain
Human
AHNAK
13.0% Increase Gene Expression Level
DAA615
Alzheimer's disease
Pathological
brain
Human
—
SeriesMorbidity
DAA748
Altered sleep parameters and patterns
Psychological
brain
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA742 | Motor function impairment evident in altered gait and balance | Physiological | nervous system | Human | — | — | |
DAA1943 | Motor coordination decreases | Physiological | musculoskeletal system, nervous system | Mouse | — | — | |
DAA1983 | Critical decline in fine motor hand movements | Physiological | nervous system | Human | — | — | |
DAA757 | Parkinsonian signs | Physiological | nervous system | Human | — | — | |
DAA1941 | Gait width increases | Physiological | nervous system | Mouse | — | — | |
DAA606 | Cancer of meninges, brain and other parts of central nervous system | Pathological | central nervous system | Human | — | SeriesMorbidity | |
DAA614 | Parkinson's disease | Pathological | central nervous system | Human | — | SeriesMorbidity | |
DAA715 | Lipid biosynthesis decreases | Physiological | central nervous system | Human | — | — | |
DAA723 | Accumulation of extracellular neuritic plaques | Physiological | brain | Human | — | — | |
DAA4 | actin, beta | Molecular | brain | Human | ACTB | 4.0% Decrease Gene Expression Level | |
DAA15 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 | Molecular | brain | Human | ATP2A2 | 9.0% Decrease Gene Expression Level | |
DAA7 | aldehyde dehydrogenase 9 family, member A1 | Molecular | brain | Human | ALDH9A1 | 10.0% Increase Gene Expression Level | |
DAA5 | actin-like 6A | Molecular | brain | Human | ACTL6A | 21.0% Increase Gene Expression Level | |
DAA235 | transgelin 3 | Molecular | brain | Human | TAGLN3 | 5.0% Decrease Gene Expression Level | |
DAA21 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | Molecular | brain | Human | ATP6V1G2 | 7.0% Decrease Gene Expression Level | |
DAA3 | actin, alpha 1, skeletal muscle | Molecular | brain | Human | ACTA1 | 16.0% Decrease Gene Expression Level | |
DAA8 | angiomotin | Molecular | brain | Human | AMOT | 10.0% Increase Gene Expression Level | |
DAA12 | adaptor-related protein complex 1, sigma 1 subunit | Molecular | brain | Human | AP1S1 | 12.0% Decrease Gene Expression Level | |
DAA1 | abhydrolase domain containing 14A | Molecular | brain | Human | ABHD14A | 3.0% Decrease Gene Expression Level | |
DAA9 | ankyrin 2, neuronal | Molecular | brain | Human | ANK2 | 20.0% Decrease Gene Expression Level | |
DAA11 | annexin A4 | Molecular | brain | Human | ANXA4 | 11.0% Increase Gene Expression Level | |
DAA22 | antizyme inhibitor 1 | Molecular | brain | Human | AZIN1 | 11.0% Decrease Gene Expression Level | |
DAA6 | AHNAK nucleoprotein | Molecular | brain | Human | AHNAK | 13.0% Increase Gene Expression Level | |
DAA615 | Alzheimer's disease | Pathological | brain | Human | — | SeriesMorbidity | |
DAA748 | Altered sleep parameters and patterns | Psychological | brain | Human | — | — |